Top Markets
#1 Cortex Cortex +174.36%
#2 GEKKO GEKKO +51.79%
#3 ADO Protocol ADO Protocol +18.52%
#4 o1.exchange o1.exchange +10.89%
#5 Official Trump Official Trump +10.62%
#6 Audiera Audiera +10.49%
#7 Status Status +10.19%
#8 aelf aelf +9.22%
#9 DAPPOS DAPPOS +8.11%
#10 Seeker Seeker +6.62%
Coin of the day
Cortex Cortex
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Classifica tra le azioni #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Prezzo delle azioni
$59.98
Ultima sincronizzazione: 2024-12-13
Capitalizzazione di mercato
$1.22B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Longboard Pharmaceuticals, Inc. (LBPH)

Categoria

Healthcare
EPS per Longboard Pharmaceuticals, Inc. (LBPH)
EPS al September 2024 TTM: $-2.24
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Longboard Pharmaceuticals, Inc., l’EPS attuale della società (TTM) è $-2.24. Alla fine del 2022, la società aveva un EPS di $-2.51 un aumento rispetto a rispetto a quello del 2021, che era di $-1.62.
Storico EPS per Longboard Pharmaceuticals, Inc. da 2020 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-2.24 -6.28%
2023 $-2.39 -4.78%
2022 $-2.51 54.94%
2021 $-1.62 97.56%
2020 $-0.82 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -873.21%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -1,338.39%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $-5.29 136.16%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 256.25%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH